Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity

Por Hayman, Thomas J, Kramp, Tamalee, Kahn, Jenna, Jamal, Muhammad, Camphausen, Kevin, Tofilon, Philip J
Publicado em 2013

The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells

Por Kahn, Jenna, Hayman, Thomas J., Jamal, Muhammad, Rath, Barbara H., Kramp, Tamalee, Camphausen, Kevin, Tofilon, Philip J.
Publicado em 2014

The ATP-Competitive mTOR Inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells

Por Hayman, Thomas J., Wahba, Amy, Rath, Barbara H., Bae, Heekyong, Kramp, Tamalee, Shankavaram, Uma T., Camphausen, Kevin, Tofilon, Philip J.
Publicado em 2013

Outcomes of resected pancreatic cancer in patients age ≥70

Por Hayman, Thomas J., Strom, Tobin, Springett, Gregory M., Balducci, Lodovico, Hoffe, Sarah E., Meredith, Kenneth L., Hodul, Pamela, Malafa, Mokenge, Shridhar, Ravi
Publicado no J Gastrointest Oncol (2015)